Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PRTG | US
0.01
0.15%
Healthcare
Biotechnology
30/06/2024
17/10/2024
6.71
7.04
7.04
6.25
Portage Biotech Inc. together with its subsidiaries researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60 an iNKT cell activator; IMM65 a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; TT-10 an adenosine receptor type 2A (A2A) inhibitor to treat A2A expressing solid tumors; TT-4 an adenosine receptor type 2B (A2B) inhibitor to treat solid tumors; TT-53 an A2A/A2B inhibitor to treat solid tumors; TT-3 an A2B inhibitor to treat colorectal and gastrointestinal cancers; and NT230-6 that is in Phase I/II clinical trials for the treatment of tumors. It also provides Nanolipogel (NLG) co-formulation platform for delivery of DNA aptamers and certain aptamer-small molecule-based combination products; and STING agonist platform a proprietary immune priming and boosting technology offers various ways to target immune stimulation towards the cancer as well as to co-deliver various signals in a single product. The company was incorporated in 1973 and is based in Tortola British Virgin Islands.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
204.5%1 month
440.2%3 months
398.7%6 months
323.7%0.27
-
2.96
0.01
0.01
-0.02
-
-
-16.04M
7.04M
7.04M
-
-
-
-
-191.03
0.01
2.48
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
2.81
Range1M
19.16
Range3M
22.91
Rel. volume
0.03
Price X volume
561.39K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Pulmatrix Inc | PULM | Biotechnology | 2.03 | 7.41M | -4.70% | n/a | 0.18% |
Alzamend Neuro Inc. Common Stock | ALZN | Biotechnology | 1.64 | 7.34M | -1.20% | n/a | 0.00% |
TFFP | TFFP | Biotechnology | 2.06 | 7.14M | -1.44% | n/a | 1.26% |
Moleculin Biotech Inc | MBRX | Biotechnology | 2.36 | 6.71M | -2.48% | n/a | 3.00% |
Purple Biotech Ltd | PPBT | Biotechnology | 4.18 | 6.55M | 1.95% | n/a | 0.89% |
Aptose Biosciences Inc | APTO | Biotechnology | 0.36 | 6.52M | -2.17% | n/a | -37.59% |
CDIO | CDIO | Biotechnology | 0.2113 | 6.47M | -7.49% | n/a | 28.31% |
Adial Pharmaceuticals Inc | ADIL | Biotechnology | 0.9701 | 6.21M | -5.82% | n/a | 0.00% |
Hoth Therapeutics Inc | HOTH | Biotechnology | 0.9 | 6.21M | -3.26% | n/a | 0.44% |
Molecular Templates Inc | MTEM | Biotechnology | 0.93 | 6.16M | 186.07% | n/a | 155.07% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a | |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.54 | 0 | -1.56% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.02 | 0.53 | Cheaper |
Ent. to Revenue | - | 4,005.99 | - |
PE Ratio | 0.27 | 40.42 | Cheaper |
Price to Book | 2.96 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 398.67 | 72.92 | Riskier |
Debt to Equity | 0.01 | -1.24 | Expensive |
Debt to Assets | 0.01 | 0.25 | Cheaper |
Market Cap | 7.04M | 3.78B | Emerging |